Glancing behind virus load variation in HIV-1 infection

Trends in Microbiology

Volumn 11, Issue 11, 2003, Pages 499-504

  Bonhoeffer, Sebastian ^a   Funk, Georg A ^a   Günthard, Huldrych F ^b   Fischer, Marek ^b   Müller, Viktor ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; RNA;

CELL COMPARTMENTALIZATION; CELL COUNT; CELL DEATH; GENE EXPRESSION; GENETIC VARIABILITY; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MATHEMATICAL MODEL; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEADY STATE; TARGET CELL; VIRUS CELL INTERACTION; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0242352481     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tim.2003.09.002     Document Type: Article

References (39)

1. Mellors J.W., et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 272:1996;1167-1170.
2. Raboud J.M., et al. Variation in plasma RNA levels, CD4 cell counts, and p24 antigen levels in clinically stable men with human immunodeficiency virus infection. J. Infect. Dis. 174:1996;191-194.
3. Deeks S.G., et al. Variance of plasma human immunodeficiency virus type 1 RNA levels measured by branched DNA within and between days. J. Infect. Dis. 176:1997;514-517.
4. O'Brien T.R., et al. Longitudinal HIV-1 RNA levels in a cohort of homosexual men. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18:1998;155-161.
5. Sabin C.A., et al. Course of viral load throughout HIV-1 infection. J. Acquir. Immune Defic. Syndr. 23:2000;172-177.
6. Wei X., et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 373:1995;117-122.
7. Ho D.D., et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 373:1995;123-126.
8. Neumann A.U., et al. HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group. AIDS. 13:1999;677-683.
9. Hatano H., et al. Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression. AIDS. 14:2000;1357-1363.
10. Oxenius A., et al. HIV-specific CD8+ T cell responses do not predict viral growth and clearance rates during structured intermittent antiretroviral therapy. J. Virol. 76:2002;10169-10175.
11. Fagard C., et al. A prospective trial of structured treatment interruptions in human immunodeficiency virus infection. Arch. Intern. Med. 163:2003;1220-1226.
12. McLean A.R., Nowak M.A. Competition between zidovudine-sensitive and zidovudine-resistant strains of HIV. AIDS. 6:1992;71-79.
13. Perelson A.S., et al. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science. 271:1996;1582-1586.
14. Bonhoeffer S., et al. Virus dynamics and drug therapy. Proc. Natl. Acad. Sci. U. S. A. 94:1997;6971-6976.
15. De Boer R.J., Perelson A.S. Target cell limited and immune control models of HIV infection: a comparison. J. Theor. Biol. 190:1998;201-214.
16. Opravil M., et al. Effects of early antiretroviral treatment on HIV-1 RNA in blood and lymphoid tissue: a randomized trial of double versus triple therapy. Swiss HIV Cohort Study. J. Acquir. Immune Defic. Syndr. 23:2000;17-25.
17. Nowak M.A., et al. HIV results in the frame. Results confirmed. Nature. 375:1995;193.
18. Perelson A.S., et al. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature. 387:1997;188-191.
19. Notermans D.W., et al. Rate of HIV-1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen. AIDS. 12:1998;1483-1490.
20. Wu H., et al. Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end points. J. Infect. Dis. 179:1999;799-807.
21. Little S.J., et al. Viral dynamics of acute HIV-1 infection. J. Exp. Med. 190:1999;841-850.
22. Stafford M.A., et al. Modeling plasma virus concentration during primary HIV infection. J. Theor. Biol. 203:2000;285-301.
23. Lindbäck S., et al. Viral dynamics in primary HIV-1 infection. AIDS. 14:2000;2283-2291.
24. Funk G.A., et al. Quantification of in vivo replicative capacity of HIV-1 in different compartments of infected cells. J. Acquir. Immune Defic. Syndr. 26:2001;397-404.
25. Markowitz M., et al. A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo. J. Virol. 77:2003;5037-5038.
26. Müller V., et al. Small variations in multiple parameters account for wide variations in HIV-1 set-points: a novel modelling approach. Proc. R. Soc. Lond. B. Biol. Sci. 268:2001;235-242.
27. Ogg G.S., et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science. 279:1998;2103-2106.
28. Hockett R.D., et al. Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA. J. Exp. Med. 189:1999;1545-1554.
29. Fischer M., et al. Residual cell-associated unspliced HIV-1 RNA in peripheral blood of patients on potent antiretroviral therapy represents intracellular transcripts. Antivir. Ther. 7:2002;91-103.
30. Sachsenberg N., et al. Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J. Exp. Med. 187:1998;1295-1303.
31. Mohri H., et al. Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science. 279:1998;1223-1227.
32. Mohri H., et al. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J. Exp. Med. 194:2001;1277-1287.
33. Stanley S., et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N. Engl. J. Med. 334:1996;1222-1230.
34. Staprans S.I., et al. Activation of virus replication after vaccination of HIV-1-infected individuals. J. Exp. Med. 182:1995;1727-1737.
35. Grossman Z., et al. Multiple modes of cellular activation and virus transmission in HIV infection: a role for chronically and latently infected cells in sustaining viral replication. Proc. Natl. Acad. Sci. U. S. A. 95:1998;6314-6319.
36. Klenerman P., et al. Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. Proc. Natl. Acad. Sci. U. S. A. 93:1996;15323-15328.
37. Herz A.V., et al. Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay. Proc. Natl. Acad. Sci. U. S. A. 93:1996;7247-7251.
38. Mittler J.E., et al. Influence of delayed viral production on viral dynamics in HIV-1 infected patients. Math. Biosci. 152:1998;143-163.
39. Mittler J.E., et al. Improved estimates for HIV-1 clearance rate and intracellular delay. AIDS. 13:1999;1415-1417.